NEW YORK (GenomeWeb News) – Finnish biotech firm Biohit said on Monday it has agreed to buy Euroclone Gastro, a subsidiary of Italian firm Euroclone that is focused on gastrointestinal diagnostics.

The deal is anticipated to close this month. Following its completion, Euroclone Gastro will form a Biohit-owned subsidiary, Biohit Healthcare, to support the distribution of Biohit's diagnostic products in Italy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.